New rabies shot moves to phase 2 safety testing in healthy volunteers
NCT ID NCT07445815
First seen Mar 11, 2026 · Last updated May 24, 2026 · Updated 6 times
Summary
This study tests a new lab-made antibody injection against the rabies virus in 200 healthy adults aged 18-60. The main goal is to check if the injection is safe and how well it produces protective antibodies. Participants will be monitored for side effects and immune response over several months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES (HEALTHY VOLUNTEERS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lanzhou Institute of Biological Products Co., Ltd.
Lanzhou, Gansu, 730000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.